In the May 2016 issue of Health Affairs , Amy Kapezynski and Aaron Kesselheim propose that the federal government invoke its patent use authority under Section 1498 to lower drug prices and increase access for breakthrough medicines in government-funded
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/06/20/government-appropriation-of-breakthrough-drug-patent-rights-would-deter-biopharmaceutical-rd-and-innovation/
Posted
Jun 20 2016, 08:00 AM
by
Health Affairs BlogHealth Affairs Blog